These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2164226)

  • 21. Characterization of the in vitro and in vivo species preference of human and murine tumor necrosis factor-alpha.
    Kramer SM; Aggarwal BB; Eessalu TE; McCabe SM; Ferraiolo BL; Figari IS; Palladino MA
    Cancer Res; 1988 Feb; 48(4):920-5. PubMed ID: 2827889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor inhibitor: purification, NH2-terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activities.
    Seckinger P; Vey E; Turcatti G; Wingfield P; Dayer JM
    Eur J Immunol; 1990 May; 20(5):1167-74. PubMed ID: 2113477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer.
    Cappuccini F; Yamamoto RS; DiSaia PJ; Grosen EA; Gatanaga M; Lucci JA; Ininns EK; Gatanaga T; Granger GA
    Lymphokine Cytokine Res; 1991 Jun; 10(3):225-9. PubMed ID: 1653048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor.
    Espevik T; Brockhaus M; Loetscher H; Nonstad U; Shalaby R
    J Exp Med; 1990 Feb; 171(2):415-26. PubMed ID: 1689365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients.
    Gatanaga T; Hwang CD; Kohr W; Cappuccini F; Lucci JA; Jeffes EW; Lentz R; Tomich J; Yamamoto RS; Granger GA
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8781-4. PubMed ID: 2174164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of receptor occupancy to the kinetics of cell death mediated by tumor necrosis factor.
    Coffman FD; Green LM; Ware CF
    Lymphokine Res; 1988; 7(4):371-83. PubMed ID: 2850412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The myxoma virus TNF-receptor homologue (T2) inhibits tumor necrosis factor-alpha in a species-specific fashion.
    Schreiber M; McFadden G
    Virology; 1994 Nov; 204(2):692-705. PubMed ID: 7941338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein.
    Himmler A; Maurer-Fogy I; Krönke M; Scheurich P; Pfizenmaier K; Lantz M; Olsson I; Hauptmann R; Stratowa C; Adolf GR
    DNA Cell Biol; 1990 Dec; 9(10):705-15. PubMed ID: 1702293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective release of tumor necrosis factor binding protein II by malignant human epidermal cells reveals protection from tumor necrosis factor alpha-mediated cytotoxicity.
    Neuner P; Klosner G; Pourmojib M; Trautinger F; Knobler R
    Cancer Res; 1994 Nov; 54(22):6001-5. PubMed ID: 7954434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of lymphocyte tumor necrosis factor receptors by IL-2.
    Owen-Schaub LB; Crump WL; Morin GI; Grimm EA
    J Immunol; 1989 Oct; 143(7):2236-41. PubMed ID: 2550551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.
    Lantz M; Gullberg U; Nilsson E; Olsson I
    J Clin Invest; 1990 Nov; 86(5):1396-1402. PubMed ID: 2173717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.
    Kohno T; Brewer MT; Baker SL; Schwartz PE; King MW; Hale KK; Squires CH; Thompson RC; Vannice JL
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8331-5. PubMed ID: 2172983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a new receptor subtype for tumor necrosis factor-alpha.
    Schwalb DM; Han HM; Marino M; Warren R; Porter A; Goh C; Fair WR; Donner DB
    J Biol Chem; 1993 May; 268(14):9949-52. PubMed ID: 7683686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity.
    Kull FC; Jacobs S; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5756-60. PubMed ID: 2994048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
    Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
    J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors.
    Rubin BY; Anderson SL; Sullivan SA; Williamson BD; Carswell EA; Old LJ
    J Exp Med; 1985 Sep; 162(3):1099-104. PubMed ID: 2993471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis.
    Grell M; Scheurich P; Meager A; Pfizenmaier K
    Lymphokine Cytokine Res; 1993 Jun; 12(3):143-8. PubMed ID: 8394147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel recombinant tumor necrosis factor-alpha mutant with increased anti-tumor activity and lower toxicity.
    Nakamura S; Kato A; Masegi T; Fukuoka M; Kitai K; Ogawa H; Ichikawa Y; Maeda M; Watanabe N; Kohgo Y
    Int J Cancer; 1991 Jul; 48(5):744-8. PubMed ID: 1649139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity.
    Loetscher H; Gentz R; Zulauf M; Lustig A; Tabuchi H; Schlaeger EJ; Brockhaus M; Gallati H; Manneberg M; Lesslauer W
    J Biol Chem; 1991 Sep; 266(27):18324-9. PubMed ID: 1655744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration.
    Slowik MR; De Luca LG; Fiers W; Pober JS
    Am J Pathol; 1993 Dec; 143(6):1724-30. PubMed ID: 7504889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.